SCHEMBL2801104

SCHEMBL2801104

CCS(=O)(=O)NC(=O)c1cnn2c(Nc3cc(C)ccc3C)c(C(=O)N3CCC4(CC3)C(C)=Cc3ccccc34)cnc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.35
KDM4E B2RXH2 6/20 0.33
PDE4B Q07343 1/20 0.33
ALDH1A1 P00352 8/20 0.32
HSD17B10 Q99714 4/20 0.32
HPGD P15428 3/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
HTT P42858 3/20 0.32
LMNA P02545 2/20 0.32
KDR P35968 1/20 0.32
TLR4 O00206 1/20 0.31
TSHR P16473 3/20 0.31
USP2 O75604 2/20 0.31
POLB P06746 1/20 0.31
GAA P10253 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
HTR1A P08908 1/20 0.31
MEN1 O00255 3/20 0.31
KMT2A Q03164 3/20 0.31
THRB P10828 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2798930 0.89 TP53 (0.40) TP53KDM4EPDE4BALDH1A1HSD17B10
SCHEMBL2799828 0.89 PDE4B (0.42) TP53KDM4EPDE4BALDH1A1HSD17B10
SCHEMBL2800805 0.88 KDM4E (0.40) TP53KDM4EALDH1A1HSD17B10HPGD
SCHEMBL2803895 0.86 PDE4B (0.37) TP53KDM4EPDE4BALDH1A1HPGD
SCHEMBL2803802 0.85 AVPR1A (0.37) TP53KDM4EPDE4BALDH1A1HSD17B10
SCHEMBL2803131 0.85 TP53 (0.38) TP53KDM4EPDE4BALDH1A1HPGD
SCHEMBL2800861 0.82 TP53 (0.39) TP53PDE4BALDH1A1POLBSMN1; SMN2
SCHEMBL2802276 0.82 PDE4B (0.44) TP53KDM4EPDE4BALDH1A1HSD17B10
SCHEMBL2804334 0.82 ALDH1A1 (0.33) TP53KDM4EPDE4BALDH1A1HSD17B10
SCHEMBL2802527 0.81 SPR (0.37) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2206714-B1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES KYOWA HAKKO KIRIN CO LTD (JP) 2015-01-21 EP disclosed
US-8729264-B2 Agent for prevention and/or treatment of skin diseases KYOWA HAKKO KIRIN CO., LTD. (JP) 2014-05-20 US disclosed
US-20100256134-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-10-07 US disclosed
EP-2206714-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES Kyowa Hakko Kirin Co., Ltd. (JP) 2010-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256134-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES TYR, CUTA, SERPINB1 TP53 241/4885KDM4E 3180/4885PDE4B 1603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.